H-2 Antigens pp 779-788 | Cite as

Pristane-Induced Arthritis in Mice: Genetic Regulation and Immunity in an Experimental Model of Arthritis

  • Joan M. Chapdelaine
  • Janey D. Whalen
  • James R. Seibold
  • Paul H. Wooley
Part of the NATO ASI Series book series (NSSA, volume 144)

Abstract

Intraperitoneal injection of 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane) caused an inflammatory arthritis in certain strains of mice. This arthritis developed in 80% – 100% of BALB/c and DBA/1 mice, but not in DBA/2, B10.RIII, B10.BR, or SWR mice, indicating regulation of susceptibility by both MHC and non-MHC genes. The BALB/c substrains also differed in their susceptibility, with the mice susceptible to ascites formation being less susceptible to arthritis and vice versa. The onset of arthritis was characterized by edema and erythema in one or more peripheral limbs. The arthritic condition persisted for over ten weeks. Several mice developed remissions and recrudescences during the course of the disease. In the majority of animals, joint deformation resulted; however, ankylosis was not detectable. Histological evaluation of the lesions showed synovial hypertrophy and pannus formation, although articular cartilage was not eroded. Periosteitis and erosions of subchondral bone were a frequent finding. Time of onset differed between strains, with DBA/1 mice developing disease 65 – 193 days after injection, and BALB/c mice, 129 – 302 days after injection. Antibodies to type II collagen were detected in sera from 75% of the arthritic mice, whereas no anti-type II antibodies developed in resistant strains. IgM RF was also detected in sera from mice immunized with pristane. Pristane-induced arthritis may represent a new model of RA.

Keywords

Articular Cartilage Subchondral Bone Mitogen Response Pannus Formation Synovial Hypertrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bedwell, A. E., Elson, C. J. and Hinton, C. E.: Immunological involvement in the pathogenesis of pristane-induced arthritis. Scand. J. Immunol. 25: 393–398, 1987.PubMedCrossRefGoogle Scholar
  2. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A. and Mosedale, B.: Immunization against heterologous type II collagen induces arthritis in mice. Nature 283: 666–668, 1980.PubMedCrossRefGoogle Scholar
  3. Hopkins, S. J., Freemont, A. J. and Jayson, M. I. V.: Pristane-induced arthritis in BALB/c mice. I. Clinical and histological features of the arthropathy. Rheumatol. Int. 5: 21–28, 1984.PubMedCrossRefGoogle Scholar
  4. Hopkins, S. J., Freemont, A. J. and Jâyson, M. I. V.: Pristane-induced arthritis in BALB/c mice. Current Topics in Micro. and Immunol. 122: 213–220, 1985.Google Scholar
  5. Pearson, C. M.: Development of arthritis, peri-arthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med. 91: 95–101, 1956.PubMedCrossRefGoogle Scholar
  6. Potter, M. and Wax, J. S.: Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: Reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J. Immunol. 127: 1591–1595, 1981.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Joan M. Chapdelaine
    • 1
    • 3
  • Janey D. Whalen
    • 1
    • 3
  • James R. Seibold
    • 2
  • Paul H. Wooley
    • 1
    • 3
  1. 1.Immunology Dept.Ayerst Laboratories Research, Inc.PrincetonUSA
  2. 2.Div. of RheumatologyUMDNJ Robert Wood Johnson Medical SchoolNew BrunswickUSA
  3. 3.SchoolNew BrunswickUSA

Personalised recommendations